Tuesday, May 23, 2017 9:22:11 AM
- Dilutive shares all bought up. No more note holders who don't care what price they're getting in the way of what investors WOULD have paid if it wasn't offered to them for so cheap.
- Big contracts expected soon.
- Did anyone notice that they didn't even list a PR firm on the big publishing yesterday? Once they PR this thing, which will presumably be soon, nature will take its course.
- Hopefully some Form 4's coming soon, but honestly I don't think it's a big deal if we don't see Form 4's. It is possible that insiders are choosing to buy Cytocom stock over IMUN stock in which case we wouldn't see Form 4's. Cytocom is probably more valuable in the long run.
- Sales are beginning in weeks I would assume. It is going to take off fast. "20% of a billion dollar market within 12-18 months" is a very big claim. But honestly, why would anyone doubt this claim? It makes sense that they would get there if they are partnering with Fidson.
- Once things get going which will be very soon, analysts will begin rating the stock, which will drive the stock further up.
Next few weeks will be epic in my opinion. It is only a matter of time."
DUKE BASKETBALL and NOTRE DAME FOOTBALL
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM